BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1583 related articles for article (PubMed ID: 27780211)

  • 1. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.
    Houben RM; Dodd PJ
    PLoS Med; 2016 Oct; 13(10):e1002152. PubMed ID: 27780211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling.
    Knight GM; McQuaid CF; Dodd PJ; Houben RMGJ
    Lancet Infect Dis; 2019 Aug; 19(8):903-912. PubMed ID: 31281059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of latent tuberculosis infection in China: Exploring solutions suitable for high-burden countries.
    Cui X; Gao L; Cao B
    Int J Infect Dis; 2020 Mar; 92S():S37-S40. PubMed ID: 32114201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis elimination and the challenge of latent tuberculosis.
    Matteelli A; Sulis G; Capone S; D'Ambrosio L; Migliori GB; Getahun H
    Presse Med; 2017 Mar; 46(2 Pt 2):e13-e21. PubMed ID: 28279508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing new diagnostic tests for latent tuberculosis infection due to multidrug-resistant strains of Mycobacterium tuberculosis - End of the road?
    Mwaba P; Chakaya JM; Petersen E; Wejse C; Zumla A; Kapata N
    Int J Infect Dis; 2020 Mar; 92S():S69-S71. PubMed ID: 32119979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of latent TB infection in areas of high TB prevalence.
    Sharma SK; Mohanan S; Sharma A
    Chest; 2012 Sep; 142(3):761-773. PubMed ID: 22948580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent tuberculosis infection: Opportunities and challenges.
    Chee CBE; Reves R; Zhang Y; Belknap R
    Respirology; 2018 Oct; 23(10):893-900. PubMed ID: 29901251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Latent Tuberculosis Infection.
    Haley CA
    Microbiol Spectr; 2017 Apr; 5(2):. PubMed ID: 28409555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.
    Sanchez-Padilla E; Ardizzoni E; Sauvageot D; Ahoua L; Martin A; Varaine F; Adatu-Engwau F; Akeche G; Salaniponi F; Bonnet M
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1036-42. PubMed ID: 23827027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National position statement for the management of latent tuberculosis infection.
    Stock D;
    Commun Dis Intell Q Rep; 2017 Sep; 41(3):E204-E208. PubMed ID: 29720068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global burden of drug-resistant tuberculosis in children: a mathematical modelling study.
    Dodd PJ; Sismanidis C; Seddon JA
    Lancet Infect Dis; 2016 Oct; 16(10):1193-1201. PubMed ID: 27342768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.
    Dye C; Scheele S; Dolin P; Pathania V; Raviglione MC
    JAMA; 1999 Aug; 282(7):677-86. PubMed ID: 10517722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan.
    Huang SF; Chen MH; Wang FD; Tsai CY; Fung CP; Su WJ
    J Microbiol Immunol Infect; 2018 Dec; 51(6):784-793. PubMed ID: 28739436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global and Regional Burden of Isoniazid-Resistant Tuberculosis.
    Yuen CM; Jenkins HE; Rodriguez CA; Keshavjee S; Becerra MC
    Pediatrics; 2015 Jul; 136(1):e50-9. PubMed ID: 26034243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taking forward the World TB Day 2016 theme 'Unite to End Tuberculosis' for the WHO Africa Region.
    Ntoumi F; Kaleebu P; Macete E; Mfinanga S; Chakaya J; Yeboah-Manu D; Bates M; Mwaba P; Maeurer M; Petersen E; Zumla A
    Int J Infect Dis; 2016 May; 46():34-7. PubMed ID: 26969406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global trends and gaps in research related to latent tuberculosis infection.
    Chaw L; Chien LC; Wong J; Takahashi K; Koh D; Lin RT
    BMC Public Health; 2020 Mar; 20(1):352. PubMed ID: 32183753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of latent tuberculosis infection and predictive factors in an urban informal settlement in Johannesburg, South Africa: a cross-sectional study.
    Ncayiyana JR; Bassett J; West N; Westreich D; Musenge E; Emch M; Pettifor A; Hanrahan CF; Schwartz SR; Sanne I; van Rie A
    BMC Infect Dis; 2016 Nov; 16(1):661. PubMed ID: 27825307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.